CEPI funds Phase 3 trial of UW Medicine COVID-19 vaccine

May 24, 2021CEPI funds Phase 3 trial of UW Medicine COVID-19 vaccineKorea’s SK bioscience will receive up to $173.4 million to assess the efficacy of a new COVID-19 vaccine from Institute for Protein Design.
Read more Read More 

Generated by Feedzy